<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>ShapeMySkills Pvt. Ltd. | Mendoza Shah | Activity</title>
	<link>https://shapemyskills.in/members/armychild1/activity/</link>
	<atom:link href="https://shapemyskills.in/members/armychild1/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Mendoza Shah.</description>
	<lastBuildDate>Mon, 25 May 2026 05:53:17 +0530</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">893fb6cb672b64ed2f75df4d1ebbb74a</guid>
				<title>Mendoza Shah posted an update: Modafinil, a wakefulness-selling agent primarily used to deal [&#133;]</title>
				<link>https://shapemyskills.in/activity/p/16666/</link>
				<pubDate>Fri, 01 May 2026 02:04:20 +0530</pubDate>

									<content:encoded><![CDATA[<p>Modafinil, a wakefulness-selling agent primarily used to deal with narcolepsy, has gained popularity beyond its medical applications. This observational research article explores the developments, motivations, and implications surrounding the acquisition of modafinil in the United States. Via a mix of anecdotal evidence, survey information, and&hellip;<span class="activity-read-more" id="activity-read-more-16666"><a href="https://shapemyskills.in/activity/p/16666/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">26c9d0479755330495e9b0afc35fd577</guid>
				<title>Mendoza Shah became a registered member</title>
				<link>https://shapemyskills.in/activity/p/16319/</link>
				<pubDate>Thu, 30 Apr 2026 01:24:55 +0530</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>